23 Nov 2022 --- A study on Crown Laboratories’ patented Xycrobe technology is reinforcing its efficacy in topically treating skin conditions and general cosmesis using an isolated, living strain of skin-relevant bacteria with a focus on the skin microbiome.Xycrobe technology harnesses the power of defendens (C. acnes defendens) – a particular strain of Cutibacterium acnes described in the research as “one of the most prolific skin-specific bacterial species” – to improve skin health and appearance.